AGM/EGMAug 7, 2026, 04:07 PM
Apyx Medical Stockholders Approve 2026 Share Plan, Elect Directors
AI Summary
Apyx Medical Corporation held its 2026 Annual Meeting of Stockholders on August 6, 2026. During the meeting, stockholders approved all proposals, including the election of five directors to the Board. They also ratified RSM US LLP as the independent registered public accounting firm for the year ending December 31, 2026. Additionally, stockholders approved a non-binding advisory resolution supporting the compensation of the company's named executive officers and adopted the 2026 Share Incentive Plan.
Key Highlights
- Stockholders elected five directors to the Board, including Stavros G. Vizirgianakis (18,051,294 votes in favor).
- Charles D. Goodwin was re-elected with 21,338,164 votes in favor.
- Lawrence J. Waldman was re-elected with 21,332,747 votes in favor.
- Minnie Baylor-Henry was re-elected with 15,400,914 votes in favor.
- Wendy Levine was re-elected with 15,395,258 votes in favor.
- RSM US LLP was ratified as the independent registered public accounting firm for 2026 with 29,814,618 votes in favor.
- A non-binding advisory resolution supporting executive officer compensation was approved with 21,458,554 votes in favor.
- The 2026 Share Incentive Plan was approved with 16,186,776 votes in favor.
Price Impact
More from APYX